Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-25 Hunt Anthony Chief Executive Officer Sale −1,699 $92.34 $157K 229,449
2020-02-25 Hunt Anthony Chief Executive Officer Sale −8,412 $91.66 $771K 221,037
2020-02-25 Hunt Anthony Chief Executive Officer Sale −1,624 $90.22 $147K 219,413
2020-02-25 Hunt Anthony Chief Executive Officer Exercise or conversion +10,210 $16.55 $169K 229,623
2020-02-25 Hunt Anthony Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −11,735 53,240
2020-02-25 Hunt Anthony Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −10,210 7,917
2020-02-24 Cox John Director Sale −100 $94.85 $9K 7,136
2020-02-24 Cox John Director Sale −4,355 $92.76 $404K 2,781
2020-02-21 DAWES KAREN A Director Sale −300 $101.06 $30K 116,734
2020-02-21 DAWES KAREN A Director Sale −945 $99.85 $94K 115,789
2020-02-21 DAWES KAREN A Director Sale −906 $99.12 $90K 114,883
2020-02-21 DAWES KAREN A Director Sale −1,849 $97.52 $180K 113,034
2019-12-16 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −295 $90.43 $27K 26,508
2019-12-05 Snodgres Jon Chief Financial Officer Exercise or conversion +2,000 $24.50 $49K 30,239
2019-12-05 Snodgres Jon Chief Financial Officer Exercise or conversion +1,957 $26.05 $51K 32,196
2019-12-05 Snodgres Jon Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −2,000 0
2019-12-05 Snodgres Jon Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −1,957 3,170
2019-09-19 Hunt Anthony Chief Executive Officer Exercise or conversion +20,000 $16.55 $331K 223,013
2019-09-19 Hunt Anthony Chief Executive Officer Sale −638 $81.82 $52K 222,375
2019-09-19 Hunt Anthony Chief Executive Officer Sale −2,510 $83.01 $208K 219,865

Page 40 of 42 · 832 trades